# Role of Metformin in Posterior Capsule Opacification

> **NCT07176338** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Vienna Institute for Research in Ocular Surgery** · enrollment: 40 (actual)

## Conditions studied

- Cataract
- Diabetes Mellitus Type 2

## Interventions

- **DIAGNOSTIC_TEST:** Blood and lens capsule samples for PK testing

## Key facts

- **NCT ID:** NCT07176338
- **Lead sponsor:** Vienna Institute for Research in Ocular Surgery
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-12
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07176338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07176338, "Role of Metformin in Posterior Capsule Opacification". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07176338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
